Tag: EU
Insurance: Not Much of a Muchness
Many policyholders believe that the insurance available on the market covering a particular type of risk is much of a muchness. The disputes about insurance cover for business interruption losses due to COVID-19 have highlighted that this assumption is misconceived. Insurance policies are not commoditised. There are no standard forms […]
EU adjusted 2020 Work Programme: product safety and consumer rights remain on the agenda
The European Commission published its adjusted Work Programme for 2020, following the impact of the COVID-19 pandemic. Product safety and consumer law initiatives remain very much on the Commission’s agenda. However, some timelines have been extended and stakeholders will be given additional time to contribute to consultations to help shape future policy and law in these areas.
WEBCAST: EU and AI – Navigating the European Approach
Cooley’s international products law team are pleased to announce the fourth event in its webinar series. This webinar will look at the European Union’s approach to Artificial Intelligence including the impact of the European Commission’s White Paper on Artificial Intelligence. The team will be joined by members of Cooley’s Technology […]
Products & Consumer Rights: Global Hot Topics
Edward Turtle and Carol Holley
Key takeaways from the Cooley products team webinar on consumer rights.
COVID-19: Weekly Life Sciences Digest – Testing Kits for COVID-19
Natasha Leskovsek, Andrew Barr, Sarah-Jane Dobson, Edward Turtle, Harriet Jones and Julia Maskell
With COVID-19 heralding unprecedented changes in the sector, our life sciences products experts provide a weekly summary of key international developments to keep you up to date.
WEBCAST: Products & Consumer Rights: Global Hot Topics
Cooley’s international products law team is pleased to announce the third event in its webcast series looking at the latest consumer rights issues product manufacturers, suppliers and other stakeholders are facing in the rapidly changing global environment. This time we will be joined by Wendy Hederman, a partner at leading Irish law […]
All Together Now – Update on Collective Redress in Europe
Edward Turtle and Carol Holley
Recent developments in relation to consumer collective redress in Europe.
2020 Vision – Looking Beyond COVID-19: Longer-Term Considerations for Supply and Manufacture of Products During COVID-19
Sarah-Jane Dobson, Andrew Barr and Richard Hopley
With COVID-19 causing a pivot or volume increase in production, companies should pause to reflect on the longer-term considerations in terms of international product safety, liability and insurance law issues.
COVID-19: Weekly Life Sciences Digest – Initiatives for Fast Tracking Treatments and New FDA Guidance
Phil Mitchell, Edward Turtle, Sana Shakir, Julia Maskell and Alicia Johnson-Cole
With COVID-19 heralding unprecedented changes in the sector, our life sciences products experts provide a weekly summary of key international developments to keep you up to date.
WEBCAST: 2020 Vision – Looking Beyond COVID-19. Longer-Term Considerations for Supply and Manufacture of Products During COVID-19
Many companies are opting to rapidly pivot into new product lines or significantly increase their production volumes. In doing this, they are relying on exceptions to, and derogations from, the usual regulatory regimes, or a flexible approach to enforcement by regulatory authorities – all motivated by the unique context of COVID-19. […]